Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma

Published:2019-03-11 Issue:5 Volume:95 Page:528-536
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Michmerhuizen Nicole L.,Leonard Elizabeth,Matovina Chloe,Harris Micah,Herbst Gabrielle,Kulkarni Aditi,Zhai Jingyi,Jiang Hui,Carey Thomas E.,Brenner J. Chad

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference53 articles.

1. In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance

2. Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab

3. Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

4. Criteria for Analyzing Interactions between Biologically Active Agents

5. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma;Birkeland;Oral Oncol,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Genome Wide CRISPR Profiling Approach Identifies Mechanisms of Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma;2024-02-20

2. Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma;Archives of Oral Biology;2023-12

3. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment;Cancers;2023-08-24

4. ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines;Cells;2023-03-30

5. Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma;Head & Neck;2022-02-27